Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups.


Journal

Epigenetics & chromatin
ISSN: 1756-8935
Titre abrégé: Epigenetics Chromatin
Pays: England
ID NLM: 101471619

Informations de publication

Date de publication:
12 02 2019
Historique:
received: 21 10 2018
accepted: 05 02 2019
entrez: 14 2 2019
pubmed: 14 2 2019
medline: 16 3 2019
Statut: epublish

Résumé

ATP-dependent chromatin remodelling complexes are responsible for establishing and maintaining the positions of nucleosomes. Chromatin remodellers are targeted to chromatin by transcription factors and non-coding RNA to remodel the chromatin into functional states. However, the influence of chromatin remodelling on shaping the functional epigenome is not well understood. Moreover, chromatin remodellers have not been extensively explored as a collective group across two-dimensional and three-dimensional epigenomic layers. Here, we have integrated the genome-wide binding profiles of eight chromatin remodellers together with DNA methylation, nucleosome positioning, histone modification and Hi-C chromosomal contacts to reveal that chromatin remodellers can be stratified into two functional groups. Group 1 (BRG1, SNF2H, CHD3 and CHD4) has a clear preference for binding at 'actively marked' chromatin and Group 2 (BRM, INO80, SNF2L and CHD1) for 'repressively marked' chromatin. We find that histone modifications and chromatin architectural features, but not DNA methylation, stratify the remodellers into these functional groups. Our findings suggest that chromatin remodelling events are synchronous and that chromatin remodellers themselves should be considered simultaneously and not as individual entities in isolation or necessarily by structural similarity, as they are traditionally classified. Their coordinated function should be considered by preference for chromatin features in order to gain a more accurate and comprehensive picture of chromatin regulation.

Sections du résumé

BACKGROUND
ATP-dependent chromatin remodelling complexes are responsible for establishing and maintaining the positions of nucleosomes. Chromatin remodellers are targeted to chromatin by transcription factors and non-coding RNA to remodel the chromatin into functional states. However, the influence of chromatin remodelling on shaping the functional epigenome is not well understood. Moreover, chromatin remodellers have not been extensively explored as a collective group across two-dimensional and three-dimensional epigenomic layers.
RESULTS
Here, we have integrated the genome-wide binding profiles of eight chromatin remodellers together with DNA methylation, nucleosome positioning, histone modification and Hi-C chromosomal contacts to reveal that chromatin remodellers can be stratified into two functional groups. Group 1 (BRG1, SNF2H, CHD3 and CHD4) has a clear preference for binding at 'actively marked' chromatin and Group 2 (BRM, INO80, SNF2L and CHD1) for 'repressively marked' chromatin. We find that histone modifications and chromatin architectural features, but not DNA methylation, stratify the remodellers into these functional groups.
CONCLUSIONS
Our findings suggest that chromatin remodelling events are synchronous and that chromatin remodellers themselves should be considered simultaneously and not as individual entities in isolation or necessarily by structural similarity, as they are traditionally classified. Their coordinated function should be considered by preference for chromatin features in order to gain a more accurate and comprehensive picture of chromatin regulation.

Identifiants

pubmed: 30755246
doi: 10.1186/s13072-019-0258-9
pii: 10.1186/s13072-019-0258-9
pmc: PMC6371444
doi:

Substances chimiques

Chromosomal Proteins, Non-Histone 0
DNA-Binding Proteins 0
Nuclear Proteins 0
SMARCA1 protein, human 0
SMARCA2 protein, human 0
Transcription Factors 0
Mi-2 Nucleosome Remodeling and Deacetylase Complex EC 3.5.1.98
Adenosine Triphosphatases EC 3.6.1.-
SMARCA4 protein, human EC 3.6.1.-
SMARCA5 protein, human EC 3.6.1.-
ATPases Associated with Diverse Cellular Activities EC 3.6.4.-
DNA Helicases EC 3.6.4.-
INO80 protein, human EC 3.6.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Références

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3740-5
pubmed: 11891299
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Mol Cell. 2002 Dec;10(6):1441-52
pubmed: 12504018
Curr Opin Cell Biol. 2003 Apr;15(2):172-83
pubmed: 12648673
J Biol Chem. 2003 Dec 19;278(51):51638-45
pubmed: 14530259
Cancer Lett. 2004 Aug 10;211(2):133-43
pubmed: 15219937
Biochem Cell Biol. 2005 Aug;83(4):405-17
pubmed: 16094444
J Biol Chem. 2005 Dec 23;280(51):41789-92
pubmed: 16263726
Science. 2006 Feb 10;311(5762):844-7
pubmed: 16469925
Nat Cell Biol. 2006 May;8(5):532-8
pubmed: 16570078
J Biol Chem. 2006 Jun 16;281(24):16279-88
pubmed: 16606615
Cell. 2006 Apr 21;125(2):315-26
pubmed: 16630819
Nature. 2006 Jul 6;442(7098):86-90
pubmed: 16728976
Nature. 2006 Aug 17;442(7104):772-8
pubmed: 16862119
Results Probl Cell Differ. 2006;41:127-48
pubmed: 16909894
Biochemistry. 2007 Feb 27;46(8):2100-10
pubmed: 17274598
Mutat Res. 2007 May 1;618(1-2):30-40
pubmed: 17350655
Nat Genet. 2008 Jul;40(7):897-903
pubmed: 18552846
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11258-63
pubmed: 19549820
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Cell Res. 2011 Mar;21(3):381-95
pubmed: 21321607
Nature. 2011 May 15;474(7351):390-4
pubmed: 21572438
Nature. 2011 Nov 3;479(7371):74-9
pubmed: 21964334
Mol Cell Biol. 2012 Jan;32(2):399-414
pubmed: 22083957
Mol Cell Biol. 2012 Apr;32(7):1312-20
pubmed: 22290435
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Cancer Cell. 2012 May 15;21(5):655-67
pubmed: 22624715
Nat Struct Mol Biol. 2012 Sep;19(9):884-92
pubmed: 22922743
Nature. 2012 Sep 6;489(7414):75-82
pubmed: 22955617
Genome Res. 2012 Dec;22(12):2497-506
pubmed: 22960375
Cancer Cell. 2013 Jan 14;23(1):9-22
pubmed: 23245995
Nucleic Acids Res. 2013 Mar 1;41(5):2797-806
pubmed: 23345616
Nat Struct Mol Biol. 2013 Mar;20(3):259-66
pubmed: 23463310
Nat Struct Mol Biol. 2013 Mar;20(3):267-73
pubmed: 23463311
PLoS Genet. 2013;9(2):e1003317
pubmed: 23468649
Genome Res. 2013 May;23(5):789-99
pubmed: 23502848
Nat Methods. 2013 May;10(5):375-6
pubmed: 23629413
Bioinformatics. 2013 Aug 15;29(16):2046-8
pubmed: 23782611
Cell. 2013 Aug 1;154(3):490-503
pubmed: 23911317
Mol Biol Cell. 2013 Oct;24(19):3025-37
pubmed: 23924899
Cell Res. 2013 Nov;23(11):1256-69
pubmed: 23938295
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Genes Dev. 2013 Dec 15;27(24):2648-62
pubmed: 24285714
Nat Methods. 2014 Jan;11(1):73-78
pubmed: 24317252
Nat Struct Mol Biol. 2014 Jan;21(1):73-81
pubmed: 24317492
Bioinformatics. 2014 May 15;30(10):1471-2
pubmed: 24470576
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3128-33
pubmed: 24520176
Elife. 2014 Apr 15;3:e02042
pubmed: 24737864
Nucleic Acids Res. 2014 Jun;42(11):e92
pubmed: 24782521
Cell Stem Cell. 2014 May 1;14(5):575-91
pubmed: 24792115
Genome Res. 2014 Sep;24(9):1421-32
pubmed: 24916973
Nature. 2014 Oct 2;514(7520):102-106
pubmed: 25119045
Nat Rev Mol Cell Biol. 2014 Nov;15(11):703-8
pubmed: 25315270
Epigenomics. 2014;6(4):397-414
pubmed: 25333849
Bioinformatics. 2015 Mar 15;31(6):960-2
pubmed: 25391400
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Mol Cell Biol. 2015 May;35(9):1588-605
pubmed: 25733687
Development. 2015 Aug 1;142(15):2641-52
pubmed: 26138476
RNA Biol. 2015;12(10):1094-8
pubmed: 26177256
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Mol Cell. 2016 Jan 7;61(1):170-80
pubmed: 26687680
Nature. 2016 Feb 4;530(7588):113-6
pubmed: 26814966
Nucleic Acids Res. 2016 Jun 2;44(10):4625-35
pubmed: 26861626
PLoS Genet. 2016 Mar 28;12(3):e1005940
pubmed: 27019336
Genome Res. 2016 Jun;26(6):719-31
pubmed: 27053337
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Genome Res. 2016 Sep;26(9):1188-201
pubmed: 27435934
Nucleic Acids Res. 2016 Sep 19;44(16):7540-54
pubmed: 27458208
Oncogene. 2017 Mar;36(10):1328-1338
pubmed: 27593931
Genome Biol. 2016 Oct 7;17(1):208
pubmed: 27717381
Nat Commun. 2016 Nov 03;7:13337
pubmed: 27808093
Wellcome Open Res. 2016 Nov 15;1:14
pubmed: 27918597
Nucleic Acids Res. 2017 Apr 7;45(6):3059-3067
pubmed: 27940560
Nature. 2017 Feb 23;542(7642):484-488
pubmed: 28166537
Nat Commun. 2017 Mar 06;8:14648
pubmed: 28262751
Nat Rev Mol Cell Biol. 2017 Jul;18(7):407-422
pubmed: 28512350
Cell. 2017 May 18;169(5):780-791
pubmed: 28525751
J Biol Chem. 2017 Jul 14;292(28):11927-11936
pubmed: 28533432
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 5;372(1731):
pubmed: 28847826
Elife. 2017 Oct 02;6:
pubmed: 28967863
Nucleic Acids Res. 2017 Oct 13;45(18):10534-10554
pubmed: 28977666
Nat Commun. 2017 Nov 7;8(1):1346
pubmed: 29116202
Nat Protoc. 2017 Dec;12(12):2478-2492
pubmed: 29120462
Methods Mol Biol. 2018;1708:267-284
pubmed: 29224149
Nat Genet. 2018 Jan;50(1):73-82
pubmed: 29255264
Nat Struct Mol Biol. 2018 Jan;25(1):61-72
pubmed: 29323272
Nat Commun. 2019 Jan 24;10(1):416
pubmed: 30679435
Nature. 1997 Sep 18;389(6648):251-60
pubmed: 9305837

Auteurs

Katherine A Giles (KA)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

Cathryn M Gould (CM)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

Qian Du (Q)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

Ksenia Skvortsova (K)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

Jenny Z Song (JZ)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

Madhavi P Maddugoda (MP)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

Joanna Achinger-Kawecka (J)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, UNSW Australia, Sydney, NSW, 2000, Australia.

Clare Stirzaker (C)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, UNSW Australia, Sydney, NSW, 2000, Australia.

Susan J Clark (SJ)

Epigenetics Research, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, UNSW Australia, Sydney, NSW, 2000, Australia.

Phillippa C Taberlay (PC)

St Vincent's Clinical School, UNSW Australia, Sydney, NSW, 2000, Australia. phillippa.taberlay@utas.edu.au.
School of Medicine, Collage of Health and Medicine, University of Tasmania, Hobart, TAS, 7000, Australia. phillippa.taberlay@utas.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH